A globally innovative narcolepsy drug makes its debut in China, while AI startup Anthropic agrees to a record $1.5 billion copyright settlement with authors
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
China’s National Medical Products Administration has approved a first-in-class drug targeting type 1 narcolepsy in adults and adolescents 16 and older.
As Chinese drugmakers churn out a record number of novel therapies, industry experts urge an overhaul of pricing, insurance and…
The country’s drug evaluation agency registered a jump in new drug and clinical trial applications, signaling a robust pivot…
The latest national drug tender seeks to curb destructive price competition while tightening quality requirements for generic…
With more drugs in clinical trials than any other country, Chinese drugmakers are now shifting focus to the high-risk,…
Chinese pharma companies are still striking global deals, but rising regulatory pressure is forcing a rethink
Global chipmakers reportedly plan July price hikes amid AI boom, while DeepSeek readies its new model rollout
